KR20190023496A - Process for producing fermented algae containing fucose and a cosmetic composition containing the same - Google Patents
Process for producing fermented algae containing fucose and a cosmetic composition containing the same Download PDFInfo
- Publication number
- KR20190023496A KR20190023496A KR1020170109346A KR20170109346A KR20190023496A KR 20190023496 A KR20190023496 A KR 20190023496A KR 1020170109346 A KR1020170109346 A KR 1020170109346A KR 20170109346 A KR20170109346 A KR 20170109346A KR 20190023496 A KR20190023496 A KR 20190023496A
- Authority
- KR
- South Korea
- Prior art keywords
- seaweed
- fermentation
- fermented
- effect
- cosmetic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
청각 또는 미역 발효 추출물의 제조법 및 이를 함유하는 화장료 조성물에 관한 것이다. 더욱 구체적으로는 a) 청각과 미역의 탈염 및 전지분유 첨가를 통한 발효 전 단계; b) 물과 혼합하고 유산균 및 효모를 접종하여 발효하는 단계; c) 상기 방법에 의하여 제조된 발효 추출물 및 이를 유효성분으로 함유하는 보습, 미백, 피부 주름 개선용 화장료 조성물에 관한 것이다. 상기 조성물은 유효성분으로서 후코스를 함유하고 있으며, 이는 화장품 원료로써 항산화 효과, 미백효과, 항염증효과, 주름개선효과 및 피부 보습 효과 등을 기대할 수 있다. And to a cosmetic composition containing the same. More specifically, a) pre-fermentation step by desalting of the hearing and seaweed and addition of whole milk powder; b) mixing with water and fermenting by inoculating lactic acid bacteria and yeast; c) a fermented extract prepared by the above method and a cosmetic composition for improving moisturizing, whitening and skin wrinkles containing the extract as an active ingredient. The composition contains fucose as an active ingredient, which can be expected as antioxidative effect, whitening effect, anti-inflammatory effect, wrinkle improving effect and skin moisturizing effect as cosmetic raw materials.
Description
본 발명은 후코스(fucose)를 함유하는 발효 해조에 제조법 및 이를 함유하는 화장품 조성물에 관한 것으로, 보다 구체적으로, 본 실험은 청각, 미역에 전지분유를 첨가하여 유산균으로 발효 추출한 것에 제조법과 이를 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a fermentation seaweed containing a fucose and a cosmetic composition containing the same, more particularly, to a method for producing fermented seaweed containing fucose, To a cosmetic composition.
해조는 바다에 사는 조류로써 녹조류, 갈조류, 홍조류, 남조류 등으로 분류되며 한국의 경우 약 500 여종이 밝혀져 있고 이 중 50 종만이 식용으로 사용된다. 해조는 광합성에 필요한 광선에 따라 해조의 서식하는 수심이 달라진다. 일반적으로 적색광은 얕은 곳에서 소멸되고 청록색은 깊은 곳까지 들어갈 수 있어, 녹조류는 비교적 얕고 밝은 장소에서 서식하며 갈조류 및 홍조류는 차례대로 점차 깊고 어두운 곳에서 서식하는 특징을 나타내고 있다. Seaweed is a sea bird, which is classified as green algae, brown algae, red algae, and cyanobacteria. In Korea, about 500 species are known, of which only 50 are used for food. Seaweeds vary in depth depending on the ray required for photosynthesis. Generally, the red light is extinguished in a shallow place and the cyan can penetrate to a deep place. The green algae are relatively shallow and live in a bright place, and the brown algae and red algae gradually appear to live in deep and dark places.
해조는 단백질과 지방의 함량이 낮고 탄수화물은 소화율이 낮아서 영양가는 적지만, 칼륨ㅇ아이오딘ㅇ칼슘 등 각종 무기염류와 비타민 A, C 등의 함량이 높고, 혈액 속의 콜레스테롤 함량 저하, 혈압강하, 동맥경화 예방 등에 탁월한 효과가 있음이 밝혀져 있다. 최근에는 많은 연구들을 통해 기능성 식품 및 기능성 화장품 원료로써 연구가 진행되고 있다.Seaweed has low content of protein and fat and low digestibility of carbohydrate, so it has low nutritional value. However, it has high content of various inorganic salts such as potassium iodine and calcium, vitamin A and C, low cholesterol content in blood, And prevention of hardening. Recently, many studies have been conducted as functional food and functional cosmetic raw materials.
사람에 피부조직은 표피층, 진피층, 피하지방층으로 나눠며, 표피는 각질층, 투명층, 과립층, 가시층, 기저층으로 구성되어 있고 진피는 표피 아래에 있는 결합조직으로 유두층과 세망층(망상층)으로 이루어져 있다. 표피층은 외부에서 들어오는 세균의 침입과 견인력, 장력, 기계적 자극으로부터 보호해 주고, 수분의 증발을 막아 인체의 항상성을 유지해 주고 수분의 증발을 막아 인체의 항상성을 유지해 준다. 진피층은 많은 모세혈관들이 분포하고 있으며 혈관은 수축과 확장을 통해 열손실을 조절하고 에크린땀샘을 통해 체온을 조절하며 피지샘에 분비되는 지방으로 피부를 윤활하게 유지해 준다. 또한, 진피 조직 내의 콜라겐, 엘라스틴, 히아루론산은 피부의 유연성과 탄력을 유지하게 하는 중요한 섬유 조직이다.The skin is divided into the epidermis, the dermis, and the subcutaneous fat layer. The epidermis consists of the stratum corneum, the transparent layer, the granular layer, the visible layer and the basal layer. The dermis is the connective tissue below the epidermis and consists of the papillary layer and the reticular layer have. The epidermal layer protects against intrusion of bacteria entering from the outside, pulling force, tension, mechanical stimulation, prevents water evaporation, maintains the homeostasis of the human body and prevents evaporation of water to maintain the homeostasis of the human body. The dermis is distributed in many capillaries. The blood vessels regulate the heat loss through contraction and expansion, regulate the body temperature through the eccrine glands, and keep the skin lubricated by sebaceous glands. In addition, collagen, elastin, and hyaluronic acid in the dermis tissue are important fiber tissues that maintain the flexibility and elasticity of the skin.
표피층의 수분함량이 10% 이하로 줄어들면 피부가 갈라지는 건조피부가 발생한다. 건조 피부의 병인은 아직 규명되지는 않았으나 피부 및 전신 질환이나 위생, 환경 및 생활 습관이 중요하다고 알려져 있으며, 표피지질 성분의 조성 변화와 경피수분손실 증가, 유해한 성분 흡수에 대한 저지력 감소를 통한 피부 장벽의 기능을 수행하는 각질층에 변화 등이 건조 피부의 발생 조건으로 알려져 있다.If the moisture content of the epidermal layer is reduced to less than 10%, dry skin with cracking of the skin occurs. Although the pathogenesis of dry skin has not yet been elucidated, it is known that skin and systemic diseases, hygiene, environment and lifestyle are important, and skin barrier, such as composition change of epidermal lipid component, increase of transdermal water loss, And the change in the stratum corneum that performs the function of the skin.
이에, 본 발명자들은 여러 천연물들에서 화장품 원료로의 응용 가능성을 연구한 결과, 녹조류인 청각과 갈조류인 미역을 락토바실러스 사케이(lactobacillus sakei, 유산균)를 이용하여 발효함으로써, 유용성분인 후코스를 함유하는 것을 확인 할 수 있었다. 이들로부터 항산화 효과, 미백효과, 항염증효과, 주름개선효과 및 피부 보습 효과 등을 측정한 결과, 우수한 화장품 원료로써의 효능을 기대할 수 있다는 것에서 발견하게 되었다.The inventors of the present invention have studied the possibility of application of various natural products to cosmetic raw materials and found that the seaweed which is a green alga and a brown algae are fermented by using lactobacillus sakei, . As a result of measuring the antioxidative effect, whitening effect, anti-inflammatory effect, wrinkle-reducing effect and skin moisturizing effect from these, it was found that the efficacy as an excellent cosmetic raw material can be expected.
본 발명은 청각 및 미역과 같은 해조를 유산균을 이용한 발효공정으로써 생성물인 발효 제조물 생산에 최적화를 기하고 해조 발효 추출물의 제조법을 확립 및 이를 함유하는 항산화, 미백, 항염증, 피부주름, 보습 개선을 위한 화장료 조성물을 제공하는 것이다.The present invention aims to optimize the production of fermented products as a product by fermentation process using seaweeds such as hearing and seaweed by lactic acid bacteria, and to establish a method of producing seaweed fermented extract and to provide antioxidant, whitening, anti-inflammatory, skin wrinkle, And to provide a cosmetic composition.
상기한 목적을 달성하기 위하여, 본 발명은 해조를 유산균으로 발효하는 과정에서 해조의 함량, 첨가제의 함량 그리고 최적배양 온도 등을 확인함으로써 최적조건을 탐색하였으며, 후코스와 같은 유효성분이 함유되어 있는 항산화, 미백, 항염증, 주름개선, 보습 효능이 있음을 규명하였다.In order to achieve the above-mentioned object, the present invention has investigated optimal conditions by examining the content of seaweed, the content of additives, and the optimal culture temperature in fermenting seaweed with lactic acid bacteria, and found that the antioxidant , Whitening, anti-inflammation, wrinkle improvement, and moisturizing effect.
상술한 바와 같이 본 발명은 청각 발효 추출물과 미역 발효 추출물의 제조법으로써, 이 생산된 화장료 조성물은 항산화, 미백, 항염증, 주름개선, 보습 효과를 지니고 있는 화장료 조성물이다.As described above, the present invention is a method for producing an auditory fermentation extract and a wakame fermentation extract. The produced cosmetic composition is a cosmetic composition having antioxidative, whitening, anti-inflammatory, wrinkle-reducing and moisturizing effects.
도 1은 건조 청각 함유에 따른 시간대별 락토바실러스 사케이의 생육 그래피
도 2는 건조 미역 함유에 따른 시간대별 락토바실러스 사케이의 생육 그래피
도 3은 첨가물 함유에 따른 유산균 발효조건 탐색
도 4는 유산균 배양 온도 및 시간에 따른 유산균 수의 변화
도 5는 유산균 배양 온도 및 시간에 따른 효소활성의 활성 변화
도 6은 청각 유산균 배양 온도 및 시간에 따른 유산균 수
도 7은 미역 유산균 배양 온도 및 시간에 따른 유산균 수
도 8은 해조 발효 추출물의 발효 전ㅇ후 항산화 활성 비교
도 9은 해조 발효 추출물의 발효 전ㅇ후 미백활성 비교
도 10은 해조 발효 추출물의 발효 전ㅇ후 미백활성 비교
도 11은 해조 발효 추출물의 발효 전ㅇ후 미백활성 비교
도 12은 해조 발효 추출물의 발효 전ㅇ후 미백활성 비교
도 13은 해조 발효 추출물의 발효 전ㅇ후 항염활성 비교
도 14은 해조 발효 추출물의 발효 전ㅇ후 elastase 활성 억제능 비교
도 15는 해조 발효 추출물의 발효 전ㅇ후 hyaluronic acid량 비교
도 16은 해조 발효 추출물의 발효 전ㅇ후 유전자 발현 양상분석
도 17은 HPLC를 활용한 후코스에 함량 확인FIG. 1 shows the growth of Lactobacillus casei according to the time of dry hearing
FIG. 2 shows the growth of Lactobacillus casei according to the time of dry seaweed supplementation
FIG. 3 is a graph showing the fermentation conditions of lactic acid bacteria
Fig. 4 shows changes in the number of lactic acid bacteria depending on the temperature and time of cultivation of lactic acid bacteria
Fig. 5 shows the change in activity of enzyme activity according to the incubation temperature and time of lactic acid bacteria
Fig. 6 is a graph showing the relationship between the number of lactic acid bacteria
Fig. 7 is a graph showing the number of lactic acid bacteria
Fig. 8 shows the comparison of antioxidative activities of fermented seaweed extracts before fermentation
9 shows the comparison of the whitening activity after fermentation of the seaweed fermentation extract
Fig. 10 shows the comparison of the whitening activity after fermentation of the seaweed fermentation extract
11 shows the comparison of the whitening activity of the seaweed fermentation extract before fermentation
Fig. 12 shows the comparison of the whitening activity of the seaweed fermentation extract before fermentation
Fig. 13 shows the comparison of anti-inflammatory activity of fermented seaweed extract before fermentation
Fig. 14 is a graph comparing the inhibitory effect of the seaweed fermentation extract on elastase activity before fermentation
Fig. 15 shows the comparison of the amount of hyaluronic acid after fermentation of the seaweed fermentation extract
FIG. 16 shows the analysis of gene expression patterns before and after fermentation of the seaweed fermentation extract
FIG. 17 shows the results of HPLC
본 발명의 화장품 조성물은 해조에 유효성분인 후코스를 함유한다. 사용하는 해조는 청각 및 미역 등이지만, 이에 한정되는 것은 아니며, 수중에서 형체를 유지하고 있는 대부분의 해조로부터 제조될 수 있다. 본 발명에서 사용하는 해조는 하기 단계에 의해 제조할 수 있다.The cosmetic composition of the present invention contains a fucose which is an active ingredient in seaweed. The seaweed used is, but not limited to, the hearing and the seaweed, and can be produced from most seaweeds that maintain their shape in water. The seaweed used in the present invention can be prepared by the following steps.
a) 청각 혹은 미역을 수세 및 탈염 후 건조한 분말에 전지분유를 첨가한 단계a) a step in which whole milk powder is added to the dried powder after washing or desalting the hearing or the seaweed
b) 위 단계에 물과 혼합하고 가열살균 및 방랭하여 유산균을 접종하는 단계b) Inoculation of lactic acid bacteria by mixing with water in the above step, sterilization by heating, and cooling
c) 적정온도로 보관하여 유산균으로 발효 후 살균 및 필터하는 단계c) sterilization and filtration after fermentation with lactic acid bacteria after storage at appropriate temperature
본 발명의 제조조건으로 확정하기 위해 아래의 실시 예 1부터 4까지를 통해 제조법을 확립하였다. 이 후 해조 발효 추출물에 효과ㅇ효능을 확인하기 위해 다양한 테스트를 하였다. 항산화 활성 테스트는 실시 예 5, 미백활성은 실시 예 6부터 9까지, 항염증활성은 실시 예 10, 주름생성 억제능은 실시 예 11, 보습에 관련되어 있는 히알루론산 함량 측정은 실시예 12, 그리고 유효성분인 후코스 함량은 실시 예 14등을 통해 확인하였다.In order to confirm the production conditions of the present invention, the production method was established through Examples 1 to 4 below. Thereafter, various tests were conducted to confirm the efficacy of the seaweed fermentation extract. The antioxidative activity test was carried out in the same manner as in Example 5, whitening activity in Examples 6 to 9, anti-inflammatory activity in Example 10, inhibition of wrinkle formation in Example 11, measurement of hyaluronic acid content in moisturizing in Example 12, The content of fucose as a component was confirmed through Example 14 and the like.
<실시 예 1>최적 발효조건 확인을 위한 탐색(해조 함량)Example 1 Search for Determination of Optimum Fermentation Condition (Seaweed Content)
유산균에 최적 발효조건을 확인하기 위해 해조 함량(0.1%, 0.5%, 1.0%, 2.0%, 3.0%)을 달리하여 80℃에서 2시간동안 살균 후, 발효 유산균인 Lactobacillus sakei를 접종하였다. 매 12시간 마다 흡광도를 측정하여 유산균에 양을 확인하여 최적 발효조건을 탐색하였다. Lactobacillus sakei , a fermented lactic acid bacterium, was inoculated after sterilization at 80 ℃ for 2 hours with different contents of seaweed (0.1%, 0.5%, 1.0%, 2.0%, and 3.0%) in order to confirm optimal fermentation conditions for lactic acid bacteria. Absorbance was measured every 12 hours and the optimum fermentation conditions were investigated by confirming the amount of lactic acid bacteria.
도 1은 건조 청각을, 도 2는 건조 미역에 함량을 달리하여 측정한 결과이며, 건조 청각의 함량은 증가 될수록 유산균에 생육 속도도 증가하지만 3.0% 이상을 함유하였을 경우에는 생육이 감소하였고 72시간이 경과되면 증가폭이 줄어들었다. 이를 종합해보면, 건조 미역에서도 미역에 함량이 증가 될수록 유산균에 생육 속도도 증가하지만 3.0% 이상을 함유하였을 경우에는 생육이 감소하였다.FIG. 1 shows the results of measurement of dry hearing, while FIG. 2 shows the results in different contents in dry seaweed. When the content of dry hearing was increased, the growth rate was increased in lactic acid bacteria. As the time elapsed, the growth rate decreased. As a result, the growth rate of L. acidophilus was increased as the content of wakame in dried seaweed increased.
<실시 예 2>최적 발효조건 확인을 위한 탐색(첨가물 함량)≪ Example 2 > Search for confirming optimum fermentation condition (additive content)
유산균에 최적 발효조건을 확인하기 위해 각 해조(청각, 미역) 2.0% 함유된 곳에 첨가물 (whole milk, 0.5%, 1.0%, 2.0%)을 넣고 80℃에서 2시간동안 살균 후, 발효 유산균인 L. sakei를 접종 후 매 12시간 마다 흡광도를 측정하여 최적 발효조건을 탐색하였다.(Whole milk, 0.5%, 1.0%, 2.0%) was added to each seaweed (hearing, seaweed) at a concentration of 2.0% in order to confirm the optimum fermentation conditions for the lactic acid bacteria. After sterilization at 80 ° C. for 2 hours, the fermented lactic acid bacteria L after the. sakei inoculum search for an optimal fermentation conditions by measuring the absorbance every 12 hours.
해조 건조 분말 2.0%은 동일하게 포함하고 첨가물인 전지분유에 함량을 달리하였을 때, 도 3과 같이 전지분유 2.0%를 포함할 경우 청각과 미역 둘 다 높게 측정되었으나, 탁도가 너무 높고 부패 가능성이 높아 적합하지 않았으며 전지분유 0.5%보다는 1.0%를 함유할 때 단 시간 안에 유산균의 수가 증가하는 것을 보여 전지분유 1.0%를 함유할 때 발효에 적합하였다.As shown in FIG. 3, when 2.0% of seaweed dried powder was contained in the same amount and the content was different in the whole powdered milk, the sensory and the seaweed contents were both high when the powdered milk containing 2.0% And the number of lactobacillus was increased in a short time when 1.0% of total milk powder was contained than 0.5% of whole milk powder, and it was suitable for fermentation when 1.0% of whole milk powder was contained.
<실시 예 3>최적 발효조건 확인을 위한 탐색(배양온도)≪ Example 3 > Searching for optimum fermentation condition (culture temperature)
발효 최적화를 위해 물리적인 조건으로 최적 배양온도를 확인하였다. 해조 건조 분말은 2.0%, 전지분유는 1.0%로 동일하게 포함하고 배양온도만을 달리하여 유산균의 총 균수 측정을 통해 최적 발효조건을 확인해 보았다.Optimal incubation temperature was determined by physical conditions to optimize fermentation. The optimum fermentation conditions were confirmed by measuring total bacterial counts of lactic acid bacteria at different cultivation temperature and containing 2.0% of seaweed powder and 1.0% of whole milk powder.
그 결과, 도 4와 도 6에서 보는 것과 같이 청각은 30℃에서 유산균 수가 가장 높게 나타났으며 미역은 28℃에서 조금 더 높게 측정되었고 두 해조 모두 25℃와 35℃에서는 유산균 생육조건이 좋을 확인할 수 있었다.As a result, as shown in FIG. 4 and FIG. 6, the highest number of lactic acid bacteria was found at 30 ° C in the hearing, and the seaweed was slightly higher at 28 ° C, and the growth conditions of lactic acid bacteria at 25 ° C and 35 ° C were good there was.
<실시 예 4>최적 발효조건 확인을 위한 탐색(효소측정)≪ Example 4 > Search for confirmation of optimal fermentation conditions (enzyme measurement)
발효 최적화를 위해 물리적인 조건으로 최적 배양온도를 확인하였다. 해조 건조 분말은 2.0%, 전지분유는 1.0%로 동일하게 포함하고 배양온도만을 달리하여 α-amylase 효소활성을 측정하여 최적 발효조건을 확인해 보았다. α-amylase 활성은 SALIVARY α-AMYLASE kit를 사용하여 측정하였다. 이 방법은 색소성 기질인 maltotriose와 연결된 2-chloro-p-nitrophenol을 이용하며, 이 기질과 α-amylase의 효소반응을 통해 2-chloro-p-nitrophenol이 생성되며, 이는 405 nm에서 분광 광도계로 측정 할 수 있다.Optimal incubation temperature was determined by physical conditions to optimize fermentation. The optimum fermentation condition was confirmed by measuring the activity of α-amylase enzyme with the same culture temperature of 2.0% for seaweed powder and 1.0% for whole milk powder. α-amylase activity was measured using a SALIVARY α-AMYLASE kit. This method uses 2-chloro-p-nitrophenol coupled with the maltotriose, which is a pigmented substrate, and 2-chloro-p-nitrophenol is produced by enzymatic reaction of α-amylase with this substrate. Can be measured.
최적 배양온도를 확인하기 위한 다른 방법으로 효소활성(α-amylase)의 활성을 측정한 결과, 도 5와 도 7에서 보는 것과 같았으며 총 생균수의 측정 결과와 동일하게 청각은 30℃에서 미역은 28℃에서 α-amylase의 효소 활성이 높게 측정되어 유산균 발효의 최적 온도임을 확인하였다.As a result of measuring the activity of α-amylase as another method for confirming the optimal culture temperature, the results were as shown in FIG. 5 and FIG. 7. As in the measurement results of total viable cell count, The enzyme activity of α-amylase was measured at 28 ℃ and it was confirmed that it was the optimal temperature for fermentation of lactic acid bacteria.
<실시 예 5>해조 발효 추출물의 발효 전ㅇ후 항산화 활성 비교(DPPH assay)Example 5 Comparison of post-fermentation antioxidant activity of seaweed fermentation extract (DPPH assay)
발효를 통한 해조 발효 추출물의 항산화 활성을 알아보기 위하여 DPPH assay를 통하여 항산화 활성을 확인 하였다. 발효가 진행된 청각과 미역에 대해서 발효 전ㅇ후의 DPPH 라디칼 소거능을 측정하였다. DPPH assay 방법으로는 시료를 60 ㎕를 취하여 0.2 mM DPPH (2,2-diphenyl-1-picrylhydrazyl) 240 ㎕와 혼합한 다음 약 37℃에서 30분 방치한 후 microplate reader로 517 nm에서 흡광도를 측정하였다. Blank는 시료의 용매를 사용하였고, control로는 시료 대신 시료의 희석 용매에 DPPH시약을 넣어 사용하였으며, 양성대조군은 L-ascorbic acid를 사용하였다. DPPH radical은 보라색을 띄고 있는데 항산화제와 반응을 하게 되면 항산화제에 의해 환원이 되어 옅은 노란색을 띄게 된다. 이러한 색의 변화를 측정하여 항산화능을 측정한다. Antioxidative activity of fermented seaweed extracts was investigated by DPPH assay. The DPPH radical scavenging ability of fermented hearing and seaweed before fermentation was measured. For the DPPH assay, 60 μl of the sample was mixed with 240 μl of 0.2 mM DPPH (2,2-diphenyl-1-picrylhydrazyl), allowed to stand at 37 ° C for 30 minutes, and the absorbance was measured at 517 nm using a microplate reader . Blank was used as a sample solvent, DPPH reagent was used as a control dilution solvent instead of a sample, and L-ascorbic acid was used as a positive control. DPPH radicals are purple, and when reacted with antioxidants, they are reduced by antioxidants and become pale yellow. The antioxidant activity is measured by measuring the color change.
그 결과는 도 8에서 처럼 청각은 400 ㎍/㎖에서 발효 전에는 43%에 소거능이 있었으나 발효 후에는 69%로 소거능이 증가하였으며 미역은 400 ㎍/㎖에서 발효 전에는 33%에 소거능을 나타냈으나 발효 후에는 65%에 소거능을 나타내 DPPH 라디컬 소거능이 발효 전 보다 발효 후에 증가하는 것을 확인하였다.As shown in FIG. 8, the hearing loss was reduced to 43% before fermentation at 400 ㎍ / ㎖, but increased to 69% after fermentation. The seaweed decreased to 33% before fermentation at 400 ㎍ / After that, it showed a scavenging ability at 65%, and it was confirmed that DPPH radical scavenging ability increased after fermentation before fermentation.
<실시 예 6>해조 발효 추출물의 발효 전ㅇ후 미백활성 비교(Tyrosinase inhibition assay)Example 6: Comparison of post-fermentation activity of a seaweed fermentation extract (Tyrosinase inhibition assay)
발효 전ㅇ후에 미백활성을 확인하기 위해 tyrosinase inhibition assay를 측정하였다. 이 측정방법으로는 B16F1 mouse melanoma 세포를 배양하여 1ㅧ105 cell/well이 되도록 12 well plate에 세포를 처리(seeding)한 후 24시간 배양하고 배지는 제거하고 시료를 농도별(100 ㎍/㎖, 200 ㎍/㎖, 400 ㎍/㎖)로 배지에 희석하여 처리 후 48시간동안 배양한다. 양성 대조군으로 arbutin을 사용하고 48시간 배양한 후 각 well를 10 mM PBS로 세척 하고, 1% Triton X-100 을 함유한 10 mM PBS 100 ㎕에 현탁시킨다. 이 현탁된 액을 vortexing 한 후 1,000 rpm에서 5분간 원심 분리하여 상층액을 활성측정 효소액으로 사용한다. 96 well plate에 이 효소액을 40 ㎕넣고 기질인 L-dopa (2 ㎎/㎖) 100 ㎕를 첨가한 후, 37℃에서 1시간 동안 반응을 진행시킨 뒤 405 ㎚에서 흡광도를 측정하여 tyrosinase의 활성도를 아래의 계산식으로 계산한다.After the fermentation, tyrosinase inhibition assay was performed to confirm the whitening activity. In this assay, B16F1 mouse melanoma cells were cultured and seeded in a 12-well plate at 1 × 10 5 cells / well. The cells were cultured for 24 hours. The medium was removed and the samples were seeded at 100 μg / , 200 [mu] g / ml, 400 [mu] g / ml) and cultured for 48 hours. Arbutin is used as a positive control and incubated for 48 hours. Each well is washed with 10 mM PBS and suspended in 100 μl of 10 mM PBS containing 1% Triton X-100. This suspension is vortexed and centrifuged at 1,000 rpm for 5 minutes. The supernatant is used as the active enzyme solution. 40 μl of this enzyme solution was added to a 96-well plate, and 100 μl of L-dopa (2 mg / ml) was added. After incubation at 37 ° C for 1 hour, the absorbance was measured at 405 nm to determine the activity of tyrosinase Calculate with the following formula.
<계산식 1><
저해율(%) = {1 - (시료 첨가군의 흡광도 ㆇ 무 첨가군의 흡광도)} X 100Inhibition rate (%) = {1 - (Absorbance of no added group of absorbance of sample added group)}
그 결과, 도 9와 같이 청각과 미역 발효 추출물에서 농도 의존적으로 tyrosinase의 활성을 억제하였다. 또한, 청각은 400㎍/㎖에서 발효 전에는 효소 활성 억제능이 64%에서 발효 후에는 76%로, 미역은 400㎍/㎖에서 발효 전에는 효소 활성 억제능이 64%에서 발효 후에는 78%로 발효 후에 효소 활성 억제능이 증가하는 것을 알 수 있었다.As a result, as shown in Fig. 9, the activity of tyrosinase was inhibited in a concentration-dependent manner in the hearing and seaweed fermentation extracts. In addition, in the case of 400 μg / ㎖ of hearing, enzyme activity inhibition ability was 64% after fermentation, 76% after fermentation before fermentation, and enzyme activity inhibition ability was 64% after fermentation at 400 ㎍ / And the activity inhibition was increased.
<실시 예 7>해조 발효 추출물의 발효 전ㅇ후 미백활성 비교(L-DOPA Oxidation inhibition assay)<Example 7> Comparison of post-fermentation activity of fermented seaweed extract (L-DOPA Oxidation inhibition assay)
발효 전ㅇ후에 미백활성을 확인하기 위해 L-DOPA Oxidation inhibition assay를 측정하였다. 이 측정방법으로는 96 well plate에 0.1 M 인산염완충액(pH 6.5)과 시료를 넣고 1.5 mM tyrosine 또는 10 mM L-DOPA를 순서대로 넣는다. 양성대조구로는 arbutin을 사용하였으며 음성대조구로는 0.1 M 인산염완충액을 사용한다. 여기에 머쉬룸 타이로시나제 500 U/ml액을 넣고 37도에서 15분 동안 반응시킨다. 반응 후 ELISA reader를 이용하여 490 nm에서 흡광도를 측정한다.L-DOPA Oxidation inhibition assay was performed to confirm whitening activity after fermentation. For this assay, add 0.1 M phosphate buffer (pH 6.5) and sample to a 96-well plate and add 1.5 mM tyrosine or 10 mM L-DOPA in that order. Arbutin was used as a positive control and 0.1 M phosphate buffer was used as a negative control. Add 500 U / ml of Mushroom Tyrosinase and incubate at 37 ° C for 15 minutes. After the reaction, the absorbance is measured at 490 nm using an ELISA reader.
그 결과, 도 10에서 보는 것과 같이 모든 시료에서 농도 의존적으로 억제능이 나타났으며 청각의 경우 400 ㎍/㎖에서 발효 전에는 효소 활성 억제능이 65%에서 발효 후에는 73%로 L-DOPA Oxidation 억제능이 증가되었으며 미역은 400 ㎍/㎖에서 발효 전에는 효소 활성 억제능이 41%에서 발효 후에는 55%로 발효 후에 효소 활성 억제능이 증가하는 것을 알 수 있었다.As a result, as shown in FIG. 10, the inhibitory effect on L-DOPA Oxidation was increased from 65% in fermentation to 73% in fermentation at 400 μg / , And the enzyme activity inhibition was increased from 41% to 55% after fermentation at 400 ㎍ / ㎖ in the seaweed before fermentation.
<실시 예 8>해조 발효 추출물의 발효 전ㅇ후 미백활성 비교(Cellular melanin synthesis inhibition assay).<Example 8> Cellulol melanin synthesis inhibition assay of fermented seaweed extract before fermentation.
세포 내 melanin 함량 측정을 통해 melanocyte 내에서의 melanin 생성량을 알아보았다. 1 ㅧ 105개의 B16F1 cell을 cell culture dish에 분주하여 24시간 동안 배양하고 3일 간의 시료 처리 후 배양 세포를 1X phosphate buffered saline(PBS)으로 씻어준 다음 10% dimethyl sulfoxide (DMSO)가 포함된 1 N sodium hydroxide (NaOH) 용액을 처리하여 80℃에서 한 시간 동안 반응시킨 후 multi-plate reader를 이용하여 475 nm에서 흡광도를 측정하였다. 전체 단백질량을 측정한 후 일정 단백질량당 멜라닌 량을 계산하였다.The amount of melanin in the melanocytes was measured by measuring the content of melanin in the cells. 1 × 10 5 B16F1 cells were plated on a cell culture dish and incubated for 24 hours. After 3 days of treatment, the cells were washed with 1 × phosphate buffered saline (PBS), and then incubated for 1 hour with 10% dimethyl sulfoxide (DMSO) N sodium hydroxide (NaOH) solution at 80 ° C for one hour. Absorbance was measured at 475 nm using a multi-plate reader. The total amount of protein was measured and then the amount of melanin per a certain amount of protein was calculated.
청각 발효 추출물(CF-F)과 미역 발효 추출물(US-F)의 발효 전ㅇ후 활성을 비교해 보았다. 그 결과, 도 11에서 보는 것과 같이 양성대조군인 알부틴의 경우 50 ㎍/㎖ 농도로 처리하였을 경우 50%, 100㎍ /㎖ 농도로 처리하였을 경우 83%정도로 멜라닌 합성을 저해하는 것으로 나타났다. 청각 발효 추출물은 발효전에는 49%에서 발효 후 57%로 멜라닌 합성억제능이 증가하였으며, 미역 발효 추출물 발효전에는 47%에서 발효 후에 50%로 멜라닌 합성이 억제되는 것을 확인하였다.The fermentation efficiency of the fermented extract (CF-F) and the seaweed fermented extract (US-F) was compared before fermentation. As a result, as shown in FIG. 11, arbutin, a positive control, inhibited melanin synthesis by 50% at a concentration of 50 μg / ml and 83% at a concentration of 100 μg / ml. The sensory evaluation showed that melanin synthesis was suppressed from 47% before fermentation to 50% after fermentation of seaweed fermented extract, while that of audible fermented extract increased from 49% to 57% after fermentation.
<실시 예 9>해조 발효 추출물의 발효 전ㅇ후 미백활성 비교(Extracellular melanin synthesis inhibition assay).Example 9 Comparison of post-fermentation activity of seaweed fermentation extract (Extracellular melanin synthesis inhibition assay).
Extracellular melanin synthesis inhibition assay는 1 ㅧ 105개의 B16F1 cell을 cell culture dish에 분주하여 24시간 동안 배양하고 3일 간의 시료 처리 후 배양한 배지를 multi-plate reader를 이용하여 475 nm에서 흡광도를 측정하여 억제능을 확인하였다.Extracellular melanin synthesis inhibition assay was performed by dividing 1 × 10 5 B16F1 cells in a cell culture dish for 24 hours and then culturing the media for 3 days. The absorbance was measured at 475 nm using a multi-plate reader, Respectively.
그 결과, 도 12에서 보는 것과 같이 양성대조군인 알부틴의 경우 50㎍/㎖ 농도로 처리하였을 경우 48%, 100㎍/㎖ 농도로 처리하였을 경우 71%정도로 멜라닌 합성을 저해하는 것으로 나타났다. 해조 발효 추출물 중 청각 발효 추출물은 발효 전 42%에서 발효 후 51%로 생성 억제능이 높아졌으며, 미역 발효 추출물 역시 발효전 42%에서 발효 후 44%로 멜라닌 생합성 억제능이 증가하는 것을 확인하였다.As a result, as shown in FIG. 12, arbutin, a positive control, inhibited melanin synthesis by 48% when treated with 50 μg / ml and 71% when treated with 100 μg / ml. In the seaweed fermented extract, the inhibitory effect of the fermented extract was increased 42% before fermentation to 51% after fermentation, and that of seaweed fermented extract also increased from 42% before fermentation to 44% after fermentation.
<실시 예 10>해조 발효 추출물의 발효 전ㅇ후 항염활성 비교.Example 10: Comparison of anti-inflammatory activity of fermented seaweed extract before fermentation.
세포에서 염증반응의 지표물질로 가장 대표적인 것이 NO(nitro oxide)를 들 수 있다. NO synthase(NOS)에 의하여 생성되는 nitric oxide(NO)는 빠른 속도로 nitrate(NO3-)와 nitrite(NO2-)로 변환되므로 총 NO3-/NO2-의 측정치를 생체내 nitric oxide 생성의 marker로서 이용할 수 있다. Nitrate Reductase를 이용하여 NO3-를 NO2-로 환원시킨 후, Griess 시약으로 NO2-의 양을 측정할 수 있다. Griess 시약을 이용한 발색반응은 NO Synthase와 Nitrate Reductase의 반응에 필수적인 NADPH에 의해 저해되는 것으로 알려져 있다.The most representative indicator of inflammatory response in cells is NO (nitro oxide). Nitric oxide (NO) is a fast speed to nitrate (NO 3-), and nitrite (NO 2-) biological conversion, so a measure of the total NO 3- / 2- to NO in nitric oxide generation to be produced by NO synthase (NOS) Can be used as a marker. Nitrate Reductase can be used to reduce NO 3 to NO 2 -, and then measure the amount of NO 2 - with the Griess reagent. It is known that the color reaction using Griess reagent is inhibited by NADPH, which is essential for NO synthase and nitrate reductase reaction.
그 결과, 도 13에서 보는 것과 같이, 염증반응 유도를 위해 LPS를 처리하고 각 시료를 처리하였다. 청각 발효 전ㅇ후 추출물을 100 ㎍/㎖ 농도로 처리하였을 경우 발효전은 50%, 발효 후는 34%로 발효 진행시 산화질소화합물의 방출이 더 줄어들어 항염 활성이 증가하는 것으로 나타났다. 또한, 미역 발효 추출물 역시 46%에서 43%로 발효 후 질소화합물의 생성을 억제하는 것으로 나타났다.As a result, as shown in FIG. 13, LPS was treated and each sample was treated to induce an inflammatory reaction. When the extract was treated with 100 ㎍ / ㎖ of the extract before the fermentation, the release of nitric oxide was decreased by 50% before fermentation and 34% after fermentation. Seaweed fermentation extract also inhibited the production of nitrogen compounds after fermentation from 46% to 43%.
<실시 예 11>해조 발효 추출물의 발효 전ㅇ후 주름생성(elastase) 억제능 비교.Example 11: Comparison of inhibition of elastase formation after fermentation of fermented seaweed extracts.
주름개선 활성 측정(Elastase inhibition assay)은 기질로서 n-succinyl-(L-Ala)3-p-nitroanilide를 사용하여 37ㅀC 30분간 기질로부터 생성되는 p-nitroanilide의 생성량 측정하는 실험이다. 각 샘플을 일정 농도가 되도록 조제하여 40 ㎕씩 96 well plate에 취하고, 50 mM Tris-HCl buffer (pH 8.6)에 녹인 2.5 U/ml porcine pancreas elastase 용액을 40 ㎕를 첨가한다. 기질로 50 mM Tris-HCl buffer (pH 8.6)에 녹인 n-succinyl-(L-Ala)3-pnitroanilide(0.5 mg/ml)을 첨가하여 30분 간 반응시킨 후 5분간 ice에 방치해 반응을 정지시킨 후 410 nm에서 흡광도를 측정한다. 주름개선 활성평가의 양성대조군으로는 Ursolic acid(U-A)를 사용한다.Elastase inhibition assay was performed to measure the amount of p-nitroanilide produced from substrates at 37 ° C for 30 min using n-succinyl- (L-Ala) 3 -p-nitroanilide as a substrate. Prepare each sample at a constant concentration, and take 40 μl of the solution in a 96-well plate. Add 40 μl of 2.5 U / ml porcine pancreas elastase solution in 50 mM Tris-HCl buffer (pH 8.6). (L-Ala) 3-pnitroanilide (0.5 mg / ml) dissolved in 50 mM Tris-HCl buffer (pH 8.6) was added to the reaction mixture for 30 minutes and the reaction was stopped for 5 minutes. And the absorbance at 410 nm is measured. Ursolic acid (UA) is used as a positive control for wrinkle improvement activity evaluation.
해조 발효추출물의 주름개선 효능을 알아보기 위하여 elastase활성 억제능을 확인한 결과, 도 14에서 보는 것과 같이, 양성대조군으로는 ursolic acid를 사용하였다. 청각 추출물은 200 ㎍/㎖농도에서 발효 전에는 59%, 발효 후에는 60%으로 elastase를 크지는 않았지만 변하였다. 미역 추출물도 200 ㎍/㎖농도에서 발효 전에는 49%, 발효 후에는 56%으로 변화가 있었다.In order to examine the wrinkle-reducing effect of the seaweed fermentation extract, ursolic acid was used as a positive control group as shown in Fig. At the concentration of 200 ㎍ / ㎖, auditory extracts showed 59% before fermentation and 60% after fermentation, but elastase was not increased but changed. At the concentration of 200 ㎍ / ㎖, the seaweed extract also changed to 49% before fermentation and 56% after fermentation.
<실시 예 12>해조 발효추출물의 발효 전ㅇ후 히알루론산(hyaluronic acid)량 비교<Example 12> Comparison of hyaluronic acid amount after fermentation of fermented seaweed extract
HaCat 세포를 2 x 105 cells/㎖ 농도로 6 well plate에 seeding 하였다. 24시간 후에 serum-free DMEM으로 2번 washing 해준 후에 serum-free DMEM 교체하고 해조 발효 추출물을 처리해주었다. 24시간 후에 15,000 x g에서 5분간 원심분리하고 상층액을 걷어내어 ELISA 할 때 까지 -20℃에서 보관하였다. Hyaluronic acid 안티바디가 코팅된 plate에 상등액을 넣고 반응 시킨 후 검량선을 그려 측정하였다.HaCat cells were seeded in 6 well plates at a concentration of 2 x 10 5 cells / ml. Twenty-four hours later, the cells were washed 2 times with serum-free DMEM, then serum-free DMEM was added and the seaweed fermentation extract was treated. After 24 hours, centrifugation was carried out at 15,000 xg for 5 minutes, and the supernatant was removed and stored at -20 ° C until ELISA. The supernatant was added to the plate coated with the hyaluronic acid anti-body and reacted, and then the calibration curve was drawn and measured.
그 결과, 도 15에서 보는 것과 같이, Hyaluronoc acid량을 확인하기 위하여 HaCat 세포를 배양한 후 해조 발효 추출물을 처리하고 배양여액을 활용하여 측정하였다. 아무것도 처리하지 않은 군에서는 144 ng/ml의 hyaluronic acid가 측정이 되었다. 청각 추출물(CF)의 경우는 100 ㎍/㎖ 처리 하였을 경우 186 ng/ml이었는데 발효 후(CF-F)는 197 ng/ml로, 미역 추출물(US)은 100 ㎍/㎖ 처리 하였을 경우 171 ng/ml이었는데 발효 후(CF-F)는 188 ng/ml로 증가되는 것을 확인 할 수 있었다.As a result, as shown in FIG. 15, HaCat cells were cultured in order to determine the amount of hyaluronoc acid, and the seaweed fermentation extract was treated and measured using culture filtrate. In the untreated group, 144 ng / ml hyaluronic acid was measured. In the case of 100 μg / ㎖ of the extract of the sea mustard extract (US), it was 186 ng / ml after the fermentation (CF-F) and 197 ng / ml and increased to 188 ng / ml after fermentation (CF-F).
<실시 예 13>해조 발효 추출물의 발효 전ㅇ후 유전자 발현 양상<Example 13> Gene expression pattern before fermentation of seaweed fermentation extract
멜라닌을 생성하는 세포인 B16F1세포에 멜라닌 생성유도를 위해 α-MSH를 100 nM을 처리하고 해조 추출물을 처리하였다. 미백관련 유전자인 TYR(Tyrosinase), MITF(Microphthalmia-associated transcription factor), TRP-1(Tyrosinase related protein-1)는 아래의 <표 1>에 있는 염기서열을 이용해 primer로 사용하였다. B16F1 cells producing melanin were treated with 100 nM of α-MSH to induce melanogenesis and treated with seaweed extract. TYR (Tyrosinase), MITF (Microphthalmia-associated transcription factor) and TRP-1 (Tyrosinase related protein-1) were used as primers using the nucleotide sequences shown in Table 1 below.
그 결과, 도 16 A 에서 보는 것과 같이, 미백에 관련되어 있는 TYR의 경우 α-MSH를 처리하였을 경우 발현양이 증가하는 것을 확인하였다. α-MSH처리 후 해조 추출물을 처리 하였을 경우 청각과 미역 추출물에서는 큰 변화가 없었다. 하지만 발효 추출물을 처리하였을 경우 청각 발효 추출물은 발현 양상이 확연히 줄어드는 것을 확인 하였으며, 미역 발효 추출물 역시 미비하지만 줄어드는 양상으로 나타났다. MITF도 α-MSH를 처리하였을 경우 발현양이 증가하였으며, 발효 전 추출물의 경우 별다른 변화가 없었으나 청각 발효 추출물과 미역 발효 추출물에서 다 발현 양상이 감소하는 것으로 나타났다. TRP-1의 경우 역시 청각, 미역 발효 추출물에서는 발현 양상이 줄어드는 것을 확인하였다.As a result, as shown in FIG. 16A, it was confirmed that the expression level of TYR associated with whitening was increased when α-MSH was treated. There was no significant change in hearing and seaweed extracts after treatment with α-MSH. However, when the fermented extract was treated, the appearance of the fermented extract was significantly reduced, and the fermented extract of the seaweed fermented was also reduced. MITF also increased the expression level when α-MSH was treated, but there was no significant change in the extract before fermentation, but the polyadenylation pattern was decreased in the auditory fermentation extract and the seaweed fermentation extract. In the case of TRP-1, it was also confirmed that the expression patterns of TRP-1 were decreased in the auditory and seaweed fermentation extracts.
(Tyrosinase) TYR
(Tyrosinase)
R : ATC TGC TAT CCC TGT GAG TG, F: GAG AAC TAA CTG GGG ATG AG
R: ATC TGC TAT CCC TGT GAG TG,
(Microphthalmia-associated transcription factor)MITF
(Microphthalmia-associated transcription factor)
R : TAG AAA CGC TGG AAG GAA GG,F: AGG GGA AAA CTT GGT GTG AG
R: TAG AAA CGC TGG AAG GAA GG,
(Tyrosinase related protein-1)TRP-1
(Tyrosinase related protein-1)
R : CAG TGA AAG TGT GCA GGA GGF: GCA CTG ATG ACT TGA TGG GA
R: CAG TGA AAG TGT GCA GGA GG
R : AGC AGC ACA TCA ACA AGA GC, F: AGC AGC ACA TCA ACA AGA GC
R: AGC AGC ACA TCA ACA AGA GC,
R : GCA GAG GTT CAG TGA TGT AG, F: GGG ACA GTG ACC TGG ACT GT
R: GCA GAG GTT CAG TGA TGT AG,
R : ACC TCT CCA CCA ATG ACC TG,F: GCC TTC TCC AAC CTC TCC TA
R: ACC TCT CCA CCA ATG ACC TG,
R : CTT GTC ACC ACC AGC AGT AG.F: GCT GTG CTC CAT AGT TTCA
R: CTT GTC ACC ACC AGC AGT AG.
도 16 B 에서 보는 것과 같이, 염증 관련되어 있는 염증관련 유전자의 발현 양상을 알아보기 위하여 Raw 264.7 세포를 사용하여 염증반응 유도를 위해서 LPS를 처리하였으며, LPS 처리시 염증관련 유전자인 IL-1β, TNF-α, COX-2, iNOS의 발현 양상이 증가하는 것을 확인 하였다. As shown in FIG. 16B, in order to examine the expression pattern of inflammation-related genes involved in inflammation, Raw 264.7 cells were treated with LPS for the induction of inflammatory reaction. IL-1β and TNF -α, COX-2, and iNOS, respectively.
Primer의 염기서열은 상기 <표 1>에 있는 것과 같이 사용하였다. IL-1β의 경우 LPS처리 후 해조 추출물을 처리 하였을 때 발현 양상이 크게 변하지 않았지만, 발효 추출물을 처리 하였을 경우 발현 양상이 확연히 줄어드는 것을 확인 하였으며, TNF-α역시 발효 추출물을 처리 하였을 경우 발현 양상이 확연히 줄어드는 것을 확인 하였다. COX-2와 iNOS의 경우는 추출물과 발효 추출물에서 발현양상이 확연히 줄어드는 것을 확인하였다.The nucleotide sequence of the primer was used as shown in Table 1 above. In the case of IL-1β, the expression pattern of LPS-treated seaweed extract did not change significantly, but the expression pattern of IL-1β was remarkably decreased when the fermented extract was treated. When TNF-α was also treated with fermented extract, Respectively. In the case of COX-2 and iNOS, the expression pattern was significantly reduced in the extracts and fermented extracts.
<실시 예 14>HPLC를 활용한 후코스(fucose) 함량 확인<Example 14> Confirmation of fucose content using HPLC
해조의 유효물질인 Fucoidan은 점성이 있는 다당체 형태로써 HPLC를 이용한 분석에 어려움이 있어 Fucoidan에 단당체 형태인 fucose가 발효 후 시료에 함유되어 있는지를 확인하였다. 유효성분인 fucose에 함량을 확인하기 위해 아래 <표 2>에 있는 조건으로 분석하여 확인하였다. 그 결과 도 17에서 보는 것과 같이, 표준품인 fucose(도 17 A.)와 같은 시간대에 peak가 있는 것으로 보아 청각 발효 추출물과 미역 발효 추출물에 fucose 단당체가 함유되어 있는 것으로 확인되었다.Fucoidan, which is an effective substance of seaweed, is a viscous polysaccharide form and it is difficult to analyze by HPLC. Fucoidan was confirmed to be a monosaccharide form fucose after fermentation. To confirm the contents of fucose as an active ingredient, analysis was conducted under the conditions shown in Table 2 below. As a result, as shown in FIG. 17, it was confirmed that the fucose monosaccharide was contained in the pericarp fermentation extract and the seaweed fermentation extract, considering that there was a peak in the same time zone as the standard product fucose (FIG. 17A).
Claims (7)
상기 발효 해조로는 청각(Ecklonia cava) 또는 미역(Undaria pinnatifida)과 같은 녹조류 혹은 갈조류를 유산균(Lactobacillus sakei)으로 발효하는 제조방법.The method according to claim 1,
The fermentation seaweed is fermented with Lactobacillus sakei as green algae or brown algae such as Ecklonia cava or Undaria pinnatifida.
(1) 청각 또는 미역의 탈염 및 전지분유 첨가를 통한 발효 전 단계; 및
(2) 물과 혼합하고 살균한 뒤, 유산균을 접종하여 해조를 발효하는 단계;
를 포함하여 이루어짐을 특징으로 하는 해조 발효물의 제조방법.The method according to claim 1,
(1) pre-fermentation step by desalting of the hearing or the seaweed and addition of whole milk powder; And
(2) mixing and sterilizing with water, inoculating the lactic acid bacteria to ferment the seaweed;
The method of manufacturing a seaweed fermented product according to claim 1,
상기 발효 전 단계에서 청각 또는 미역을 0.01% 내지 5.0%을 함유하는 것을 특징으로 하며; 상기 발효 단계에서 살균은 80℃에서 2시간 살균하고 40℃까지 냉각한 뒤, 유산균 접종을 1x103 cell/ml 내지 1x109 cell/ml을 접종하여 발효하며 배양온도를 25℃ 내지 37℃로 발효하는 것에 의해 수행됨을 특징으로 하는 해조 발효물의 제조방법.The method of claim 3,
Characterized in that it contains 0.01% to 5.0% of hearing or sea mustard in the pre-fermentation step; In the fermentation step, sterilization is carried out at 80 ° C for 2 hours, followed by cooling to 40 ° C. The lactic acid bacteria inoculation is inoculated at 1 × 10 3 cells / ml to 1 × 10 9 cells / ml and fermented at a temperature of 25 ° C to 37 ° C ≪ RTI ID = 0.0 > 1, < / RTI >
상기 발효물 또는 건조분말을, 화장품 총 중량 대비 0.01 내지 100%를 첨가한 것을 특징으로 하는 기초 또는 색조 화장품 조성물.5. The method of claim 4,
Wherein the fermented product or the dry powder is added in an amount of 0.01 to 100% based on the total weight of the cosmetic product.
상기 화장품 부류에 유연 화장수, 젤, 수용성 리퀴드, 밀크로션, 영양크림, 마사지 크림, 에센스, 수중유(O/W) 또는 유중수(W/O)형의 에멀젼, 페이스크성 또는 고체 무수생성물, 소구체를 사용한 수성 상에서의 오일 분산물, 이온성 또는 비이온성 형태의 지질 소포체의 형태, 연고, 클렌징 폼, 클렌징 워터, 팩 또는 보디오일 등의 기초 화장품 제품군과 수중유형 또는 유중수형 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이섀도우, 마스카라, 치크칼라 및 아이브로우 펜슬류로 이루어진 색조 화장품 제품군 중 하나에 제형으로 하는 화장품 조성물.6. The method of claim 5,
The emulsion, facust or solid anhydrous product of the oil-in-water (O / W) type or water-in-oil type (W / O) type, Such as an oil dispersion in an aqueous phase using a sphere, a lipid vesicle form in an ionic or non-ionic form, an ointment, a cleansing foam, a cleansing water, a pack or a body oil, and an aqueous or milky makeup base, foundation, Wherein the cosmetic composition is formulated into one of a color cosmetics product line comprising skin cover, lipstick, lip gloss, face powder, two way cake, eye shadow, mascara, cheek color and eyebrow pencil.
상기 화장품 조성물은 항산화 효과, 미백효과, 항염증효과, 주름개선효과 및 피부 보습 효과 등을 특징으로 하는 화장료 조성물.
6. The method of claim 5,
The cosmetic composition is characterized by an antioxidant effect, a whitening effect, an anti-inflammatory effect, a wrinkle-reducing effect, and a skin moisturizing effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170109346A KR20190023496A (en) | 2017-08-29 | 2017-08-29 | Process for producing fermented algae containing fucose and a cosmetic composition containing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170109346A KR20190023496A (en) | 2017-08-29 | 2017-08-29 | Process for producing fermented algae containing fucose and a cosmetic composition containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20190023496A true KR20190023496A (en) | 2019-03-08 |
Family
ID=65801506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170109346A Ceased KR20190023496A (en) | 2017-08-29 | 2017-08-29 | Process for producing fermented algae containing fucose and a cosmetic composition containing the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20190023496A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200081599A (en) * | 2018-12-27 | 2020-07-08 | 강일코스팜 주식회사 | Cosmetic composition comprising seaweed fermented extract |
| CN114672519A (en) * | 2022-02-24 | 2022-06-28 | 广州市巧美化妆品有限公司 | Thallus laminariae/hot spring water fermentation broth, product containing thallus laminariae/hot spring water fermentation broth, and preparation method and application of thallus laminariae/hot spring water fermentation broth |
| KR102453568B1 (en) * | 2021-12-21 | 2022-10-14 | 주식회사 아미코스메틱 | Composition for moisturizing and anti-inflammation comprising fermented Codium fragile extract fermented by inoculating Bacillus safensis strain |
-
2017
- 2017-08-29 KR KR1020170109346A patent/KR20190023496A/en not_active Ceased
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200081599A (en) * | 2018-12-27 | 2020-07-08 | 강일코스팜 주식회사 | Cosmetic composition comprising seaweed fermented extract |
| KR102453568B1 (en) * | 2021-12-21 | 2022-10-14 | 주식회사 아미코스메틱 | Composition for moisturizing and anti-inflammation comprising fermented Codium fragile extract fermented by inoculating Bacillus safensis strain |
| CN114672519A (en) * | 2022-02-24 | 2022-06-28 | 广州市巧美化妆品有限公司 | Thallus laminariae/hot spring water fermentation broth, product containing thallus laminariae/hot spring water fermentation broth, and preparation method and application of thallus laminariae/hot spring water fermentation broth |
| CN114672519B (en) * | 2022-02-24 | 2022-11-15 | 广州市巧美化妆品有限公司 | Undaria pinnatifida/hot spring water fermentation liquor, product containing same, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102553057B1 (en) | Compositions comprising skin derived lactic acid bacteria having effects of anti-oxidation, anti-inflammation and whitening | |
| KR101826145B1 (en) | Saccharomyces cerevisiae HEH EHWA and Autolysis Extract Manufactured Using Thereof | |
| JP2010138147A (en) | Melanogenesis inhibitor, antioxidant, anti-inflammatory agent, external preparation for skin, and food and beverage | |
| KR102173646B1 (en) | Streptococcus salivarius sbk4 strain isolated from skin and functional cosmetic composition comprising Streptococcus salivarius sbk4 strain | |
| KR101634668B1 (en) | Cosmetic composition comprising fermented extract of mistletoe for anti-oxidation or whitening | |
| KR20160074116A (en) | Cosmetic composition containing Crataegis fructus fermented extract | |
| KR20190023496A (en) | Process for producing fermented algae containing fucose and a cosmetic composition containing the same | |
| KR100438009B1 (en) | A cosmetic composition containing an extract of Grifola frondosa | |
| KR102572032B1 (en) | Ak1954 strains and skin external composition using the same | |
| KR20210155989A (en) | Composition Comprising Lactobacillus sakei, Culture Fluid, or Culture Fluid Extract thereof with Anti-Wrinkling and Elasticity, Skin Cell Regeneration, and Skin Barrier Property as Active Ingredient | |
| KR102759587B1 (en) | Composition with Skin Whitening, Moisturizing, Barrier Strengthening, Exfoliating, and Itch Improvement Property Comprising Complex Strain of Lactobacillus sp. as Active Ingredient | |
| KR20230158328A (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising rice by-product extracts fermented by lactic acid bacteria | |
| KR102668617B1 (en) | Leuconostoc mesenteroides strain and cosmetic composition containing the same | |
| KR101724526B1 (en) | Cosmetic Composition Containing Fermentative Extract of Chenopodium quinoa Willd as Active Ingredient | |
| WO2023128728A1 (en) | Composition for skin function improvement | |
| KR20160045289A (en) | Cosmetic Composition for Whitening of the Skin Comprising the Extract of Fermented Zea Mays Silk | |
| KR102194314B1 (en) | Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain | |
| KR20190081333A (en) | Manufacturing method for fermented product of aronia and cosmetic composition using the same | |
| KR20130099277A (en) | A cosmetic composition comprising hydrolysates of ecklonia cava | |
| CN112522128B (en) | Pantoea wallisii Lumiteria strain and composition comprising the strain culture solution | |
| JP6375087B2 (en) | Cosmetics | |
| KR102139000B1 (en) | Antioxidant, anti-wrinkle, whitening and antibiotic cosmetic composition comprising fermented Methyl Sulfonyl methane extract and the preparation method of the same | |
| KR102862280B1 (en) | Composition for Improving Skin Conditions Comprising Extract of Dunaliella Salina Fermented by Lactic Acid Bacteria as Active Ingredient | |
| KR102329921B1 (en) | Composition for Improving Skin Conditions Extracts of Swallow's Nest Fermented by Novel Strain of Lactobacillus sp. as Active Ingredient | |
| KR102811035B1 (en) | Cosmetic composition containing Lactobacillus fermentum GFC230809 derived from makgeolli and its fermented product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170829 |
|
| PA0201 | Request for examination | ||
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 20171019 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20180912 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190326 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20190930 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20190326 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20180912 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |